Health Care · Medicinal Chemicals & Botanical Products · Nasdaq · CIK 1683541 · FYE Mar 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $2.72Day −0.73%Mkt cap $153M1Y −43.1%Off 52W high −59.2%Vol (1Y) 64.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,410 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest14.2% of sh out |
| Days to cover6.8d |
| 13F net flow (QoQ)−1.12% |
| Top-10 13F concentration81.7% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)CAD 343.3M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (CAD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−35.5% |
| 1Y−43.1% |
| 3Y−48.9% |
| 5Y−93.7% |
| 10Y−93.3% |
| Since incept. (ann.)−23.8% |
Total return through 2026-07-28 · series begins 2014-07-15. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)64.6% |
| Ann. volatility (3Y)95.0% |
| Sharpe (1Y)−0.57 |
| Sharpe (3Y)0.21 |
| Max drawdown (1Y)−58.6% |
| Max drawdown (3Y)−73.7% |
| Beta (3Y vs SPY)−1.08 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Tidal Investments LLC | 1.2M | $4M | 2.22% | +8.8% |
| GOLDMAN SACHS GROUP INC | 1.1M | $3M | 1.88% | +6.4% |
| RENAISSANCE TECHNOLOGIES LLC | 758,181 | $2M | 1.35% | −1.6% |
| NATIONAL BANK OF CANADA /FI/ | 271,290 | $887,203 | 0.48% | +1527.5% |
| MORGAN STANLEY | 259,055 | $847,112 | 0.46% | −35.9% |
| CITADEL ADVISORS LLC | 252,312 | $825,060 | 0.45% | +1.3% |
| AdvisorShares Investments LLC | 171,110 | $559,530 | 0.30% | −7.6% |
| UBS Group AG | 152,268 | $497,916 | 0.27% | +65.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for ACB.
